Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Takeover/Way Undervalued
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(99)
•••
Comment by Hockeyzon Sep 05, 2016 10:44pm
86 Views
Post# 25208806

RE:RE:RE:RE:RE:RE:RE:Takeover/Way Undervalued

RE:RE:RE:RE:RE:RE:RE:Takeover/Way UndervaluedFine, the purchaser does not pay out the loans.  Then, the purchase price could be say $16 and the company earns at least $4.80 (after all interest costs,etc.).  The return is at least 30% using the expected future earnings since the purchase price is much lower (with keeping the debt).
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities